180 related articles for article (PubMed ID: 18590927)
1. Impaired binding of thrombin to thrombomodulin is associated with risk of deep vein thrombosis.
Suehisa E; Kawasaki T; Toku M; Hidaka Y
Thromb Res; 2008; 123(1):85-92. PubMed ID: 18590927
[TBL] [Abstract][Full Text] [Related]
2. [Progression from a routine examination to a study. Having come this far, what should be done from now? A thrombosis risk factor study].
Suehisa E
Rinsho Byori; 2008 Oct; 56(10):924-9. PubMed ID: 19068790
[TBL] [Abstract][Full Text] [Related]
3. High levels of coagulation factor XI as a risk factor for venous thrombosis.
Meijers JC; Tekelenburg WL; Bouma BN; Bertina RM; Rosendaal FR
N Engl J Med; 2000 Mar; 342(10):696-701. PubMed ID: 10706899
[TBL] [Abstract][Full Text] [Related]
4. Thrombin generation in patients after acute deep-vein thrombosis.
ten Cate-Hoek AJ; Dielis AW; Spronk HM; van Oerle R; Hamulyák K; Prins MH; ten Cate H
Thromb Haemost; 2008 Aug; 100(2):240-5. PubMed ID: 18690343
[TBL] [Abstract][Full Text] [Related]
5. Detection of decreased response to activated protein C during pregnancy by an endogenous thrombin potential-based assay.
Sugimura M; Kobayashi T; Kanayama N; Terao T
Semin Thromb Hemost; 1999; 25(5):497-502. PubMed ID: 10625209
[TBL] [Abstract][Full Text] [Related]
6. Thrombin generation and D-dimer concentrations in a patient cohort investigated for venous thromboembolism. Relations to venous thrombosis, factor V Leiden and prothrombin G20210A. The LIST study.
Chaireti R; Jennersjö C; Lindahl TL
Thromb Res; 2009 Jun; 124(2):178-84. PubMed ID: 19232683
[TBL] [Abstract][Full Text] [Related]
7. Activated protein C levels in Behçet's disease and risk of venous thrombosis.
Navarro S; Ricart JM; Medina P; Vayá A; Villa P; Todolí J; Estellés A; Micó ML; Aznar J; España F
Br J Haematol; 2004 Aug; 126(4):550-6. PubMed ID: 15287949
[TBL] [Abstract][Full Text] [Related]
8. An imbalance of pro- vs anti-coagulation factors in plasma from patients with cirrhosis.
Tripodi A; Primignani M; Chantarangkul V; Dell'Era A; Clerici M; de Franchis R; Colombo M; Mannucci PM
Gastroenterology; 2009 Dec; 137(6):2105-11. PubMed ID: 19706293
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human soluble thrombomodulin delivers bounded thrombin to antithrombin III: thrombomodulin associates with free thrombin and is recycled to activate protein c.
Aritomi M; Watanabe N; Ohishi R; Gomi K; Kiyota T; Yamamoto S; Ishida T; Maruyama I
Thromb Haemost; 1993 Sep; 70(3):418-22. PubMed ID: 8259541
[TBL] [Abstract][Full Text] [Related]
10. Hyperhomocysteinaemia as a risk factor for deep-vein thrombosis.
Unlü Y; Keleş S; Becit N; Koçoğullari CU; Koçak H; Bakan E
Eur J Vasc Endovasc Surg; 2005 Sep; 30(3):315-8. PubMed ID: 15963742
[TBL] [Abstract][Full Text] [Related]
11. Sialic acid is an inflammation marker associated with a history of deep vein thrombosis.
Reganon E; Vila V; Martínez-Sales V; Vayá A; Mira Y; Ferrando F; Aznar J
Thromb Res; 2007; 119(1):73-8. PubMed ID: 16500696
[TBL] [Abstract][Full Text] [Related]
12. [Changes of blood coagulative and fibrinolytic system and function of pulmonary vascular endothelium after therapy in patients with acute pulmonary thromboembolism].
Pang BS; Wang C; Lu Y; Yang YH; Xing GH; Mao YL; Huang XX; Zhai ZG
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3074-8. PubMed ID: 18261355
[TBL] [Abstract][Full Text] [Related]
13. Haemostatic changes in patients with deep vein thrombosis.
Trifiletti A; Scamardi R; Pizzoleo MA; Soraci S; Nevoso A; Bagnato L; Barbera N
Panminerva Med; 1997 Mar; 39(1):21-3. PubMed ID: 9175416
[TBL] [Abstract][Full Text] [Related]
14. Thrombin generation in first-degree relatives of patients with venous thromboembolism who have factor V Leiden. A pilot study.
Couturaud F; Duchemin J; Leroyer C; Delahousse B; Abgrall JF; Mottier D;
Thromb Haemost; 2008 Jan; 99(1):223-8. PubMed ID: 18217158
[TBL] [Abstract][Full Text] [Related]
15. Elevated endogenous thrombin potential is associated with an increased risk of a first deep venous thrombosis but not with the risk of recurrence.
van Hylckama Vlieg A; Christiansen SC; Luddington R; Cannegieter SC; Rosendaal FR; Baglin TP
Br J Haematol; 2007 Sep; 138(6):769-74. PubMed ID: 17760809
[TBL] [Abstract][Full Text] [Related]
16. Evidence that the protein C activation pathway amplifies the inhibition of thrombin generation by recombinant human thrombomodulin in plasma.
Ohishi R; Watanabe N; Aritomi M; Gomi K; Kiyota T; Yamamoto S; Ishida T; Maruyama I
Thromb Haemost; 1993 Sep; 70(3):423-6. PubMed ID: 8259542
[TBL] [Abstract][Full Text] [Related]
17. The endogenous thrombin potential and the risk of venous thromboembolism.
Tripodi A; Martinelli I; Chantarangkul V; Battaglioli T; Clerici M; Mannucci PM
Thromb Res; 2007; 121(3):353-9. PubMed ID: 17560633
[TBL] [Abstract][Full Text] [Related]
18. Increased thrombin generation in splanchnic vein thrombosis is related to the presence of liver cirrhosis and not to the thrombotic event.
Chaireti R; Rajani R; Bergquist A; Melin T; Friis-Liby IL; Kapraali M; Kechagias S; Lindahl TL; Almer S
Thromb Res; 2014 Aug; 134(2):455-61. PubMed ID: 24913997
[TBL] [Abstract][Full Text] [Related]
19. Haplotype of thrombomodulin gene associated with plasma thrombomodulin level and deep vein thrombosis in the Japanese population.
Sugiyama S; Hirota H; Kimura R; Kokubo Y; Kawasaki T; Suehisa E; Okayama A; Tomoike H; Hayashi T; Nishigami K; Kawase I; Miyata T
Thromb Res; 2007; 119(1):35-43. PubMed ID: 16507317
[TBL] [Abstract][Full Text] [Related]
20. Measurement of a newly developed thrombomodulin addition activated partial thromboplastin time assay in patients with deep venous thrombosis.
Suehisa E; Toku M; Kawasaki T; Kanakura Y
Haemostasis; 2001; 31(1):26-31. PubMed ID: 11408746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]